Search
Close this search box.

NIIMBL Collaborates with International Pharmaceutical Quality (IPQ)

NIIMBL has entered into an agreement with International Pharmaceutical Quality (IPQ) to produce content relevant to the NIIMBL community.

 

As part of the agreement, IPQ will produce articles on the industry/regulator dialogue related to the NIIMBL mission. These stories will help the NIIMBL community better understand the key manufacturing and control regulatory issues facing industry and how NIIMBL can play a role in facilitating solutions and promoting regulatory harmonization. You can find links to IPQ content on this page.

 

As an added benefit of the agreement, academic and other non-industry members will receive complimentary access to the extensive library of content available on IPQpubs.com. For access, please complete the form below. Industry members are encouraged to use their organization’s existing IPQ credentials. For industry members who are not already IPQ subscribers, IPQ will offer an introductory discount of 50% from regular published fees. For subscription information, contact Peter Blachly (Peter@IPQpubs.com).

 

Read a recent piece on the NIIMBL presentation at the Biomanufacturing Summit at the University of Massachusetts Lowell in September here. Academic and non-profit NIIMBL members can also sign up for access to IPQpubs.com.

 

About International Pharmaceutical Quality (IPQ)

Widely read by manufacturers, suppliers, regulatory agencies, consultants, research universities, and law firms, IPQ covers emerging drug, biologic and combination product CMS and GMP issues and developments. It tracks and publishes detailed reports of industry/regulatory dialogue on the key issues related to biologic product development and manufacturing. IPQ’s comprehensive coverage serves as a valuable resource for decision-makers in the pharmaceutical community. 

Become a member

We offer a variety of membership options that give you the flexibility to choose your organization’s level of engagement based on technology interests and priorities.